Intravitreal Avastin as an adjunct in patients with proliferative diabetic retinopathy undergoing pars plana vitrectomy

Objective: Intravitreal Bevacizumab (Avastin, Genentech Inc., San Francisco, CA) (IVB) has been shown to cause regression of neovessels in proliferative diabetic retinopathy due to its anti-angiogenic effects. This study was performed to investigate the role of Avastin as an adjunct to the managemen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaman, Yawar, Rehman, Aziz-ur, Memon, Abdul Fattah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publicaitons 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809263/
https://www.ncbi.nlm.nih.gov/pubmed/24353583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809263/
https://www.ncbi.nlm.nih.gov/pubmed/24353583

Ejemplares similares